Beijing Wantai Biological Pharmacy Enterprise (SHA:603392) fell to first-half attributable net loss of 144.0 million yuan, compared with profit of 260.5 million yuan the previous year.
Losses per share stood at 0.11 yuan, versus earnings per share of 0.21 yuan a year ago, according to a Thursday filing with the Shanghai bourse.
The pharmaceutical company's operating revenue declined 38% year over year to 843.6 million yuan from 1.37 billion yuan.
Shares of the company rose 1% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments